JP2018043767A - Medicine supplying apparatus - Google Patents

Medicine supplying apparatus Download PDF

Info

Publication number
JP2018043767A
JP2018043767A JP2016179787A JP2016179787A JP2018043767A JP 2018043767 A JP2018043767 A JP 2018043767A JP 2016179787 A JP2016179787 A JP 2016179787A JP 2016179787 A JP2016179787 A JP 2016179787A JP 2018043767 A JP2018043767 A JP 2018043767A
Authority
JP
Japan
Prior art keywords
medicine
drug
collides
colliding
supply device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016179787A
Other languages
Japanese (ja)
Other versions
JP6830642B2 (en
Inventor
佳樹 松久
Yoshiki Matsuhisa
佳樹 松久
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takazono Technology Inc
Original Assignee
Takazono Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takazono Technology Inc filed Critical Takazono Technology Inc
Priority to JP2016179787A priority Critical patent/JP6830642B2/en
Publication of JP2018043767A publication Critical patent/JP2018043767A/en
Application granted granted Critical
Publication of JP6830642B2 publication Critical patent/JP6830642B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Containers And Plastic Fillers For Packaging (AREA)
  • Basic Packing Technique (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a medicine supplying apparatus which reduces splashing of the medicine and is easy to clean.SOLUTION: The medicine supplying apparatus includes: at least one medicine supplying part for supplying a medicine; and a passage part through which the medicine supplied by the medicine supplying part passes. The passage part includes: a plate-like collided member 21 made from an elastically deformable material to allow for collision with the medicine; and a cushioning member 22 for supporting the collided member 21 by a surface opposite the surface to which the medicine collides. The cushioning member 22 is made from a material which is lower in both repulsiveness and hardness, compared with the material from which the collided member 21 is made.SELECTED DRAWING: Figure 10

Description

本発明は、薬剤供給装置に関するものである。   The present invention relates to a medicine supply device.

実願昭60−37614号(実開昭61−153701号)のマイクロフィルム(特許文献1)には、錠剤包装機が記載されている。この文献では、錠剤通路を通じて薬剤を落下させる際に、錠剤通路の硬質壁との衝突によって錠剤が破損したり、錠剤が跳ね返りながら落下することで落下時間が長くなったりすることを防ぐ目的で、錠剤通路に軟質シートを吊り下げた構成が記載されている。   A microfilm (Patent Document 1) of Japanese Utility Model Application No. 60-37614 (Japanese Utility Model Application No. 61-153701) describes a tablet packaging machine. In this document, when a drug is dropped through the tablet passage, the tablet is damaged due to a collision with the hard wall of the tablet passage, or for the purpose of preventing the drop time from being prolonged by falling while the tablet bounces, A configuration in which a soft sheet is suspended in the tablet passage is described.

特許文献1に記載された装置では、錠剤収容容器から送出された錠剤が軟質シートに衝突することで、送出時の水平方向の力が軟質シートによって吸収され、錠剤は軟質シートに沿って落下する。これにより、薬剤が包装機構部に達するまでの時間を短縮することができる。   In the apparatus described in Patent Document 1, the tablet delivered from the tablet container collides with the soft sheet, so that the horizontal force at the time of delivery is absorbed by the soft sheet, and the tablet falls along the soft sheet. . Thereby, time until a chemical | medical agent reaches a packaging mechanism part can be shortened.

実願昭60−37614号(実開昭61−153701号)のマイクロフィルムMicrofilm of Japanese Utility Model No. 60-37614 (Japanese Utility Model Application No. 61-153701)

錠剤が軟質シートに衝突すると、軟質シートに錠剤の粉が付着する場合がある。軟質シートに錠剤の粉が付着している状態のまま使用を続けると、軟質シートに付着していた錠剤の粉が、不所望なタイミングで落下したり、他の錠剤に付着したりする可能性がある。そのようなことが起こると異物の混入となってしまう。そこで、そのような事態を避けるために軟質シートを清掃する必要がある。   When the tablet collides with the soft sheet, the powder of the tablet may adhere to the soft sheet. If you continue to use the tablet while the powder is still attached to the soft sheet, the powder of the tablet attached to the soft sheet may drop at an undesired timing or adhere to other tablets. There is. If this happens, foreign matter will be mixed. Therefore, it is necessary to clean the soft sheet in order to avoid such a situation.

しかし、軟質シートを吊り下げているだけの状態では、軟質シートが変形しやすいので、清掃しにくい。   However, when the soft sheet is simply suspended, the soft sheet is easily deformed and is difficult to clean.

そこで、本発明は、薬剤の跳ねを防止することができ、かつ、清掃が容易な薬剤供給装置を提供することを目的とする。   Then, an object of this invention is to provide the chemical | medical agent supply apparatus which can prevent the splash of a chemical | medical agent and is easy to clean.

上記目的を達成するため、本発明に基づく薬剤供給装置は、薬剤を供給する少なくとも1つの薬剤供給部と、上記薬剤供給部から供給された薬剤が通過する通路部とを備え、上記通路部は、上記薬剤が衝突する部材であって弾性変形可能な板状の被衝突部材と、上記被衝突部材を上記薬剤が衝突する面とは逆の面から支持する緩衝部材とを備え、上記緩衝部材は、上記被衝突部材に比べて低反発かつ低硬度の材料で形成されている。   In order to achieve the above object, a drug supply device according to the present invention includes at least one drug supply unit that supplies a drug, and a passage unit through which the drug supplied from the drug supply unit passes. A member that collides with the drug and is elastically deformable, and a buffer member that supports the collided member from a surface opposite to a surface against which the drug collides. Is formed of a material having low repulsion and low hardness as compared with the above-mentioned impacted member.

本発明によれば、板状の被衝突部材を、低反発かつ低硬度の材料で形成された緩衝部材が支持しているので、薬剤の跳ねを防止することができる。また、薬剤が衝突する面から被衝突部材21を押さえつけることもできるので、清掃が容易となる。   According to the present invention, since the shock-absorbing member formed of a low-repulsion and low-hardness material supports the plate-shaped collision target member, it is possible to prevent the drug from splashing. Moreover, since the colliding member 21 can be pressed from the surface where the medicine collides, cleaning becomes easy.

本発明に基づく実施の形態1における薬剤供給装置の斜視図である。It is a perspective view of the chemical | medical agent supply apparatus in Embodiment 1 based on this invention. 本発明に基づく実施の形態1における薬剤供給装置の扉などを開けた状態の部分斜視図である。It is a fragmentary perspective view in the state where the door etc. of the medicine supply device in Embodiment 1 based on the present invention were opened. 本発明に基づく実施の形態1における薬剤供給装置の上部筐体を側方から見たときの部分断面図である。It is a fragmentary sectional view when the upper housing | casing of the chemical | medical agent supply apparatus in Embodiment 1 based on this invention is seen from the side. 本発明に基づく実施の形態1における薬剤供給装置の前板を外した状態での正面図である。It is a front view in the state where the front board of the medicine supply device in Embodiment 1 based on the present invention was removed. 受け構造の第1の例の平面図である。It is a top view of the 1st example of a receiving structure. 図5におけるVI−VI線に関する矢視断面図である。It is arrow sectional drawing regarding the VI-VI line in FIG. 受け構造の第2の例の平面図である。It is a top view of the 2nd example of a receiving structure. 図7におけるVIII−VIII線に関する矢視断面図である。It is arrow sectional drawing regarding the VIII-VIII line in FIG. 受け構造の第3の例の斜視図である。It is a perspective view of the 3rd example of a receiving structure. ホッパの1つの斜面に受け構造が取り付けられた状態の一例の断面図である。It is sectional drawing of an example of the state in which the receiving structure was attached to one slope of a hopper. 幹線通路の面に受け構造が取り付けられた状態の一例の断面図である。It is sectional drawing of an example in the state in which the receiving structure was attached to the surface of the main passage.

(実施の形態1)
(構成)
図1〜図9を参照して、本発明に基づく実施の形態1における薬剤供給装置について説明する。
(Embodiment 1)
(Constitution)
With reference to FIGS. 1-9, the chemical | medical agent supply apparatus in Embodiment 1 based on this invention is demonstrated.

本実施の形態における薬剤供給装置101は、処方箋に基づいて薬剤を供給する。処方箋は、医師が患者に交付する。処方箋には、処方情報が記載されている。処方情報は薬剤情報を含む。薬剤情報は、薬名、分量、用法および用量を含む。薬剤供給装置101は、薬剤として、固形の薬剤を供給する。固形の薬剤としては、錠剤、丸剤、カプセル剤などが挙げられる。薬剤供給装置101は、処方箋に基づいて薬剤を包装する薬剤包装装置に備えられてもよい。   The drug supply device 101 in the present embodiment supplies a drug based on a prescription. The doctor will give the prescription to the patient. The prescription includes prescription information. The prescription information includes drug information. The drug information includes the drug name, dosage, usage and dose. The medicine supply device 101 supplies a solid medicine as a medicine. Examples of solid drugs include tablets, pills, capsules and the like. The medicine supply apparatus 101 may be provided in a medicine packaging apparatus that packages medicine based on a prescription.

本実施の形態における薬剤供給装置101の外観を図1に示す。薬剤供給装置101は、筐体1を備える。筐体1は上部筐体2と下部筐体3とを含む。上部筐体2の正面側の少なくとも一部には扉6a,6bが開閉可能なように配置されている。扉6a,6bの大部分は透明な材料で形成されている。図1では、扉6a,6bの奥に複数の薬剤供給部10が配列されているのが見えている。薬剤供給装置101は、操作部と表示部とを兼ねる部分としてパーソナルコンピュータ9を備える。パーソナルコンピュータ9には、処方箋に基づく処方情報が入力される。パーソナルコンピュータ9は、ディスプレイ4とキーボード5とを備える。パーソナルコンピュータ9の代わりに他の装置であってもよい。操作部と表示部とを兼ねる部分は、パーソナルコンピュータに限らず、たとえばタブレット端末のようなものであってもよい。操作部と表示部とは完全に別々の装置であってもよい。図1に示すように、薬剤供給装置101は、パーソナルコンピュータ9の他にさらに操作部7を備えていてもよい。薬剤供給装置101は、扉6a,6bより低い位置に前板8を備える。   An appearance of the medicine supply apparatus 101 in the present embodiment is shown in FIG. The medicine supply device 101 includes a housing 1. The housing 1 includes an upper housing 2 and a lower housing 3. Doors 6a and 6b are arranged at least partially on the front side of the upper housing 2 so as to be openable and closable. Most of the doors 6a and 6b are made of a transparent material. In FIG. 1, it can be seen that a plurality of medicine supply units 10 are arranged in the back of the doors 6a and 6b. The medicine supply apparatus 101 includes a personal computer 9 as a part serving as both an operation unit and a display unit. The personal computer 9 receives prescription information based on a prescription. The personal computer 9 includes a display 4 and a keyboard 5. Other devices may be used instead of the personal computer 9. The portion serving as both the operation unit and the display unit is not limited to a personal computer, and may be a tablet terminal, for example. The operation unit and the display unit may be completely separate devices. As shown in FIG. 1, the medicine supply device 101 may further include an operation unit 7 in addition to the personal computer 9. The medicine supply device 101 includes a front plate 8 at a position lower than the doors 6a and 6b.

薬剤供給装置101の扉6aを開け、その奥にあるいくつかの部分を引き出したところを図2に示す。扉6aの奥には収容部11がある。収容部11は、複数の薬剤供給部10を収容している。収容部11の奥には背面カバー12が配置されている。背面カバー12はヒンジおよびアーム13を介して収容部11と接続されている。上部筐体2内に収まっているときには、背面カバー12は収容部11に当接しているが、上部筐体2から引き出したときには、背面カバー12は収容部11から離れるように変位することができる。背面カバー12は収容部11に対向するように面15を有する。収容部11の背面には開口部39が配列されている。背面カバー12の下端には開口部16が設けられている。   FIG. 2 shows a state in which the door 6a of the medicine supply apparatus 101 is opened and several portions in the back are pulled out. There is an accommodating portion 11 in the back of the door 6a. The storage unit 11 stores a plurality of drug supply units 10. A back cover 12 is disposed at the back of the accommodating portion 11. The back cover 12 is connected to the accommodating portion 11 via a hinge and an arm 13. The back cover 12 is in contact with the housing portion 11 when it is within the upper housing 2, but the back cover 12 can be displaced away from the housing portion 11 when pulled out from the upper housing 2. . The back cover 12 has a surface 15 so as to face the accommodating portion 11. Openings 39 are arranged on the back surface of the accommodating portion 11. An opening 16 is provided at the lower end of the back cover 12.

薬剤供給装置101の上部筐体2を側方から見たときの断面図を図3に示す。図中左側が正面側であり、図中右側が背面側である。上下方向に複数の薬剤供給部10が並んでいる。紙面奥手前方向にも複数の薬剤供給部10が並んでいる。複数の薬剤供給部10の各々には、複数の薬剤が収容されている。すなわち、たとえば薬剤が錠剤である場合には、1つの薬剤供給部10の中に複数錠の薬剤が収容されている。複数の薬剤供給部10のうちいずれか1つの薬剤供給部10に注目した場合、1つの薬剤供給部10の中には基本的に同種の薬剤のみが収容されている。複数の薬剤供給部10に注目した場合、原則として別々の薬剤供給部10には異なる種類の薬剤がそれぞれ収容されている。ただし、使用頻度が高い薬剤については、複数の薬剤供給部10にわたって同種類の薬剤が収容されていてもよい。複数の薬剤供給部10の各々は、それぞれの内部に収容している薬剤を供給することができる。薬剤供給部10の並びの背後を覆うように背面カバー12が配置されており、背面カバー12の内部空間は上下方向に延在する幹線通路35となっている。各薬剤供給部10の背面側端部近傍には、通路37が接続されている。通路37は斜面38を有する。薬剤供給部10から排出される薬剤は、通路37を通過し、開口部39を通過して幹線通路35に入り、重力によって落下していく。薬剤は、通路37から幹線通路35に入る際に面15に衝突してもよい。   FIG. 3 shows a cross-sectional view of the upper housing 2 of the medicine supply device 101 when viewed from the side. The left side in the figure is the front side, and the right side in the figure is the back side. A plurality of medicine supply units 10 are arranged in the vertical direction. A plurality of medicine supply units 10 are also arranged in the direction toward the back of the page. Each of the plurality of drug supply units 10 contains a plurality of drugs. That is, for example, when the medicine is a tablet, a plurality of tablets of medicine are stored in one medicine supply unit 10. When attention is paid to any one of the plurality of drug supply units 10, basically only the same type of drug is accommodated in one drug supply unit 10. When attention is paid to the plurality of drug supply units 10, in principle, different types of drugs are accommodated in the separate drug supply units 10, respectively. However, for a medicine that is frequently used, the same kind of medicine may be accommodated across the plurality of medicine supply units 10. Each of the plurality of medicine supply units 10 can supply medicines accommodated therein. The back cover 12 is disposed so as to cover the back of the row of the medicine supply units 10, and the internal space of the back cover 12 is a main passage 35 extending in the vertical direction. A passage 37 is connected to the vicinity of the rear side end of each medicine supply unit 10. The passage 37 has a slope 38. The medicine discharged from the medicine supply unit 10 passes through the passage 37, passes through the opening 39, enters the main passage 35, and falls by gravity. The drug may collide with the surface 15 when entering the main passage 35 from the passage 37.

薬剤供給装置101の前板8を外したところを図4に示す。図4では、ホッパ30a,30bが見えている。ホッパ30a,30bは、幹線通路35からそれぞれ落下してくる薬剤を受け入れ、さらに目的地へと導くための構造体である。ホッパは、上が広く下が狭い通路を有する。ホッパ通路31aまたはホッパ通路31bから落下してきた薬剤はホッパ30aへと入る。一方、ホッパ通路31cまたはホッパ通路31dから落下してきた薬剤はホッパ30bへと入る。ホッパ30aは下端にホッパ出口32aを有する。ホッパ30bは下端にホッパ出口32bを有する。   The place which removed the front board 8 of the chemical | medical agent supply apparatus 101 is shown in FIG. In FIG. 4, the hoppers 30a and 30b are visible. The hoppers 30a and 30b are structures for receiving medicines falling from the main passage 35 and leading them to a destination. The hopper has a passage that is wide at the top and narrow at the bottom. The medicine dropped from the hopper passage 31a or the hopper passage 31b enters the hopper 30a. On the other hand, the medicine dropped from the hopper passage 31c or the hopper passage 31d enters the hopper 30b. The hopper 30a has a hopper outlet 32a at the lower end. The hopper 30b has a hopper outlet 32b at the lower end.

ホッパ30aは面14a,14bを有する。ホッパ30bは面14c,14d,14eを有する。面14a,14b,14c,14d,14eはいずれも法線ベクトルが上向き成分を含むような向きで設けられた面である。面14a,14b,14c,14d,14eにはそれぞれ後述する受け構造が貼られている。ここでは法線ベクトルが上向き成分を含むような向きで設けられた面のみに受け構造を設けた例を示したが、このような例に限らない。法線ベクトルが上向き成分を含まない向きで設けられた面にも受け構造が貼られていてもよい。   The hopper 30a has surfaces 14a and 14b. The hopper 30b has surfaces 14c, 14d, and 14e. Each of the surfaces 14a, 14b, 14c, 14d, and 14e is a surface provided in such an orientation that the normal vector includes an upward component. Each of the surfaces 14a, 14b, 14c, 14d, and 14e has a receiving structure that will be described later. Here, an example is shown in which the receiving structure is provided only on the surface in which the normal vector includes an upward component. However, the present invention is not limited to this example. The receiving structure may also be attached to the surface where the normal vector is provided in the direction not including the upward component.

受け構造の第1の例を図5に示す。受け構造は、被衝突部材21と緩衝部材22とを含む。図5におけるVI−VI線に関する矢視断面図を図6に示す。被衝突部材21はホッパの通路の形状に合わせた形状となっている。被衝突部材21は長方形とは限らず不規則な形状であってもよい。図5においては、被衝突部材21の外周に沿って、被衝突部材21の裏側に緩衝部材22が配置されている。   A first example of the receiving structure is shown in FIG. The receiving structure includes a collision target member 21 and a buffer member 22. FIG. 6 shows a cross-sectional view taken along the line VI-VI in FIG. The colliding member 21 has a shape that matches the shape of the passage of the hopper. The colliding member 21 is not limited to a rectangle but may be an irregular shape. In FIG. 5, a buffer member 22 is disposed on the back side of the collision target member 21 along the outer periphery of the collision target member 21.

図3に示した幹線通路35の面15にも被衝突部材21が貼られていてもよい。受け構造の第2の例を図7に示す。図7におけるVIII−VIII線に関する矢視断面図を図8に示す。このようなものが面15に貼られていてもよい。   The collision target member 21 may be attached to the surface 15 of the main passage 35 shown in FIG. A second example of the receiving structure is shown in FIG. FIG. 8 shows a cross-sectional view taken along the line VIII-VIII in FIG. Such a thing may be stuck on the surface 15.

受け構造の第3の例を図9に示す。1つの平面はなるべく1つの受け構造で覆うことが好ましいが、複数の受け構造を並べることで1つの平面を覆うこととしてもよい。   A third example of the receiving structure is shown in FIG. One plane is preferably covered with one receiving structure as much as possible, but one plane may be covered by arranging a plurality of receiving structures.

図5〜図9に示した例では、被衝突部材21の外形寸法に比べて緩衝部材22の外形寸法の方がわずかに小さくなっているが、これはあくまで一例に過ぎず、同じ外形寸法であってもよい。緩衝部材22の端が被衝突部材21の端に比べて後退しているとは限らず、いわゆる面一(つらいち)であってもよい。逆に、被衝突部材21の端が緩衝部材22の端に比べて後退していてもよい。   In the example shown in FIGS. 5 to 9, the outer dimension of the buffer member 22 is slightly smaller than the outer dimension of the impacted member 21, but this is only an example, and the same outer dimension is used. There may be. The end of the buffer member 22 is not necessarily retracted relative to the end of the impacted member 21, and may be so-called flush. Conversely, the end of the impacted member 21 may be retracted relative to the end of the buffer member 22.

薬剤供給装置101は、薬剤を供給する少なくとも1つの薬剤供給部10と、薬剤供給部10から供給された薬剤が通過する通路部とを備える。この通路部は、薬剤が衝突する部材であって弾性変形可能な板状の被衝突部材21と、被衝突部材21を薬剤が衝突する面とは逆の面から支持する緩衝部材22とを備える。緩衝部材22は、被衝突部材21に比べて低反発かつ低硬度の材料で形成されている。「通路部」は、たとえば幹線通路35を含む。「通路部」は、たとえばホッパ30a,30bを含む。   The drug supply device 101 includes at least one drug supply unit 10 that supplies a drug, and a passage unit through which the drug supplied from the drug supply unit 10 passes. The passage portion includes a plate-like collided member 21 that is a member that collides with the medicine and can be elastically deformed, and a buffer member 22 that supports the colliding member 21 from a surface opposite to the surface on which the medicine collides. . The buffer member 22 is formed of a material having low repulsion and low hardness as compared with the impacted member 21. The “passage section” includes, for example, a main passage 35. The “passage portion” includes, for example, hoppers 30a and 30b.

(作用・効果)
本実施の形態では、通路部が弾性変形可能な板状の被衝突部材21を備え、この被衝突部材21を、低反発かつ低硬度の材料で形成された緩衝部材22が支持しているので、薬剤の跳ねを防止することができる。薬剤が衝突する面とは逆の面から緩衝部材22が被衝突部材21を支持しているので、薬剤が衝突する面から被衝突部材21を押さえつけることもでき、清掃も容易となる。本実施の形態によれば、このようにして清掃が容易な薬剤供給装置とすることができる。
(Action / Effect)
In the present embodiment, the passage portion is provided with a plate-like impacted member 21 that can be elastically deformed, and the impacted member 21 is supported by a buffer member 22 formed of a material having low repulsion and low hardness. , Can prevent the drug from splashing. Since the buffer member 22 supports the collided member 21 from the surface opposite to the surface on which the medicine collides, the colliding member 21 can be pressed from the surface on which the medicine collides, and cleaning becomes easy. According to this Embodiment, it can be set as the chemical | medical agent supply apparatus which is easy to clean in this way.

本実施の形態で示したように、緩衝部材22は、被衝突部材21のうち薬剤が衝突する部位を避けた領域において被衝突部材21に重なっていることが好ましい。「薬剤が衝突する部位」とは、たとえば被衝突部材21の中央部である。この構成を採用することにより、薬剤は、被衝突部材21のうち緩衝部材22が背後にある領域ではなく、背後に緩衝部材22がない領域で被衝突部材21に衝突するので、衝突時には被衝突部材21は奥に向かって弾性変形することができ、衝撃を吸収することができる。これにより、薬剤の跳ねを効果的に低減することができる。   As shown in the present embodiment, it is preferable that the buffer member 22 overlaps the impacted member 21 in a region where the drug collides with the impacted member 21. The “part where the medicine collides” is, for example, the central part of the colliding member 21. By adopting this configuration, the medicine collides with the colliding member 21 not in the region where the buffer member 22 is behind but in the region where the buffer member 22 is not behind. The member 21 can be elastically deformed toward the back, and can absorb an impact. Thereby, the splash of a medicine can be reduced effectively.

本実施の形態で示したように、緩衝部材22は、枠状に設けられていることが好ましい。この構成を採用することにより、緩衝部材22は被衝突部材21を安定して支持しつつ、中央部分を自由に変形できる状態にしておくことができる。したがって、衝撃を吸収しやすく、薬剤の跳ねを効果的に低減することができる。   As shown in the present embodiment, the buffer member 22 is preferably provided in a frame shape. By adopting this configuration, the buffer member 22 can stably support the impacted member 21 while keeping the center portion freely deformable. Therefore, it is easy to absorb the impact, and the drug splash can be effectively reduced.

緩衝部材22は、被衝突部材21の外縁に沿うように線状に設けられていることが好ましい。この構成を採用することにより、緩衝部材22は、少ない面積で効率良く被衝突部材21を支持することができる。   It is preferable that the buffer member 22 is linearly provided along the outer edge of the collision target member 21. By adopting this configuration, the buffer member 22 can efficiently support the impacted member 21 with a small area.

ホッパ30aの1つの斜面に受け構造が取り付けられた状態の一例を図10に示す。被衝突部材21の上側の空間は、ホッパ通路31aである。受け構造を斜面に取り付ける場合には、薬剤が引っ掛かることを避けるために、図10に示すように、受け構造の上端に隙間ができないように取り付けることが好ましい。この例では、受け構造の上端が、縦に延在する壁と合う形状となっている。   An example of a state in which the receiving structure is attached to one slope of the hopper 30a is shown in FIG. The space above the collision target member 21 is a hopper passage 31a. When the receiving structure is attached to the slope, it is preferable to attach the receiving structure so that there is no gap at the upper end of the receiving structure as shown in FIG. In this example, the upper end of the receiving structure has a shape that matches a vertically extending wall.

幹線通路35の面15に受け構造が取り付けられた状態の一例を図11に示す。図11では、幹線通路35が紙面奥手前方向に延在している。図2に示したように背面カバー12は複数本の幹線通路35を一括して囲む構造であってもよいが、図11では説明の便宜のために、1つの背面カバー12の中に1本の幹線通路35のみが設けられている例が示されている。幹線通路35が直線状である場合には、図7または図9に示したような受け構造も使用可能である。   An example of the state in which the receiving structure is attached to the surface 15 of the main passage 35 is shown in FIG. In FIG. 11, the main passage 35 extends in the front direction on the paper surface. As shown in FIG. 2, the back cover 12 may have a structure that collectively surrounds a plurality of main passages 35, but in FIG. 11, one back cover 12 is provided for convenience of explanation. An example in which only the main line passage 35 is provided is shown. When the main passage 35 is straight, a receiving structure as shown in FIG. 7 or 9 can also be used.

上記通路部は、薬剤が衝突する側とは逆の側に向かって被衝突部材21が弾性変形する量を制限するように被衝突部材21に間隙を介して対向するように配置された背面部23を備えることが好ましい。図10、図11に示した例では、この条件が満たされている。この構成を採用することにより、被衝突部材21を背面部23に押し付けた状態で清掃をすることが可能となるので、清掃が容易となる。   The passage portion is arranged so as to face the colliding member 21 via a gap so as to limit the amount of elastic deformation of the colliding member 21 toward the side opposite to the side on which the medicine collides. 23 is preferably provided. In the example shown in FIGS. 10 and 11, this condition is satisfied. By adopting this configuration, it becomes possible to perform cleaning in a state in which the colliding member 21 is pressed against the back surface portion 23, so that cleaning becomes easy.

上記少なくとも1つの薬剤供給部10は、上下方向に並んで配置された複数の薬剤供給部10を含み、被衝突部材21の上下方向の長さは、複数の薬剤供給部10の上下方向の並びの長さに対応しており、被衝突部材21は一体的に形成されていることが好ましい。このように被衝突部材52が十分な長さにわたって一体的に形成されていれば、通路部において薬剤が衝突する面を、継ぎ目がない構造とすることができるので、薬剤を円滑に誘導することができる。また、被衝突部材52に一体的で継ぎ目がないことにより、通路部の清掃も容易となる。   The at least one medicine supply unit 10 includes a plurality of medicine supply units 10 arranged side by side in the vertical direction, and the vertical length of the collision target member 21 is the vertical arrangement of the plurality of medicine supply units 10. It is preferable that the colliding member 21 is integrally formed. If the colliding member 52 is integrally formed over a sufficient length in this way, the surface where the medicine collides in the passage portion can be made into a seamless structure, so that the medicine can be guided smoothly. Can do. Further, since the impacted member 52 is integral and seamless, the passage portion can be easily cleaned.

緩衝部材22は、発泡性樹脂で形成されていることが好ましい。この構成を採用することにより、受け構造は衝撃を吸収しやすくなり、薬剤の跳ねを効果的に低減することができる。   The buffer member 22 is preferably made of a foamable resin. By adopting this configuration, the receiving structure can easily absorb the impact and can effectively reduce the splashing of the medicine.

被衝突部材21は、超高分子量ポリエチレン樹脂で形成されていることが好ましい。この構成を採用することにより、耐摩耗性、耐薬品性に優れた被衝突部材を実現することができる。また、薬剤が跳ね返りにくい構造を実現することができる。   The colliding member 21 is preferably made of ultra high molecular weight polyethylene resin. By adopting this configuration, it is possible to realize a collided member having excellent wear resistance and chemical resistance. In addition, it is possible to realize a structure in which the drug is difficult to rebound.

ここまで、複数の薬剤供給部が一定平面に沿って平行に配列された構造の薬剤供給装置を例にとって説明してきたが、薬剤供給装置はこのような構造のものに限らない。たとえば複数の薬剤供給部が円筒形に配列された薬剤供給装置においても、本発明を適用することが可能である。   Up to this point, the drug supply apparatus having a structure in which a plurality of drug supply units are arranged in parallel along a certain plane has been described as an example. However, the drug supply apparatus is not limited to such a structure. For example, the present invention can be applied to a drug supply device in which a plurality of drug supply units are arranged in a cylindrical shape.

薬剤供給部の数は実施の形態1で「少なくとも1つ」と述べたように、1以上あればよく、たとえば薬剤供給部の数が1つである薬剤供給装置においても、本発明を適用することは可能である。   As described in Embodiment 1, “at least one”, the number of drug supply units may be one or more. For example, the present invention is applied to a drug supply device having one drug supply unit. It is possible.

なお、上記実施の形態のうち複数を適宜組み合わせて採用してもよい。
なお、今回開示した上記実施の形態はすべての点で例示であって制限的なものではない。本発明の範囲は特許請求の範囲によって示され、特許請求の範囲と均等の意味および範囲内でのすべての変更を含むものである。
In addition, you may employ | adopt combining suitably two or more among the said embodiment.
In addition, the said embodiment disclosed this time is an illustration in all the points, Comprising: It is not restrictive. The scope of the present invention is defined by the terms of the claims, and is intended to include any modifications within the scope and meaning equivalent to the terms of the claims.

1 筐体、2 上部筐体、3 下部筐体、4 ディスプレイ、5 キーボード、6a,6b 扉、7 操作部、8 前板、9 パーソナルコンピュータ、10 薬剤供給部、11 収容部、12 背面カバー、13 アーム、14a,14b,14c,14d,14e 面、15 面、16 開口部、21 被衝突部材、22 緩衝部材、23 背面部、30a,30b ホッパ、31a,31b,31c,31d ホッパ通路、32a,32b ホッパ出口、35 幹線通路、37 通路、38 斜面、39 開口部、101 薬剤供給装置。   DESCRIPTION OF SYMBOLS 1 Case, 2 Upper case, 3 Lower case, 4 Display, 5 Keyboard, 6a, 6b Door, 7 Operation part, 8 Front plate, 9 Personal computer, 10 Drug supply part, 11 Storage part, 12 Back cover, 13 arm, 14a, 14b, 14c, 14d, 14e surface, 15 surface, 16 opening, 21 impacted member, 22 buffer member, 23 back surface, 30a, 30b hopper, 31a, 31b, 31c, 31d hopper passage, 32a , 32b Hopper outlet, 35 main passage, 37 passage, 38 slope, 39 opening, 101 drug supply device.

Claims (8)

薬剤を供給する少なくとも1つの薬剤供給部と、
前記薬剤供給部から供給された薬剤が通過する通路部とを備え、
前記通路部は、前記薬剤が衝突する部材であって弾性変形可能な板状の被衝突部材と、
前記被衝突部材を前記薬剤が衝突する面とは逆の面から支持する緩衝部材とを備え、
前記緩衝部材は、前記被衝突部材に比べて低反発かつ低硬度の材料で形成されている、薬剤供給装置。
At least one drug supply unit for supplying a drug;
A passage section through which the medicine supplied from the medicine supply section passes,
The passage portion is a member that collides with the medicine and is a plate-like impacted member that can be elastically deformed; and
A shock-absorbing member that supports the colliding member from a surface opposite to the surface on which the medicine collides,
The said buffer member is a chemical | medical agent supply apparatus formed with the material of low repulsion and low hardness compared with the said to-be-collision member.
前記緩衝部材は、前記被衝突部材のうち前記薬剤が衝突する部位を避けた領域において前記被衝突部材に重なっている、請求項1に記載の薬剤供給装置。   The drug supply device according to claim 1, wherein the buffer member overlaps the collided member in a region where the drug collides among the collided members. 前記緩衝部材は、枠状に設けられている、請求項1または2に記載の薬剤供給装置。   The medicine supply device according to claim 1 or 2, wherein the buffer member is provided in a frame shape. 前記緩衝部材は、前記被衝突部材の外縁に沿うように線状に設けられている、請求項1から3のいずれかに記載の薬剤供給装置。   The medicine supply device according to any one of claims 1 to 3, wherein the buffer member is linearly provided along the outer edge of the collision target member. 前記通路部は、前記薬剤が衝突する側とは逆の側に向かって前記被衝突部材が弾性変形する量を制限するように前記被衝突部材に間隙を介して対向するように配置された背面部を備える、請求項1から4のいずれかに記載の薬剤供給装置。   The passage portion is disposed so as to face the colliding member with a gap therebetween so as to limit the amount of elastic deformation of the colliding member toward the side opposite to the side on which the medicine collides. The chemical | medical agent supply apparatus in any one of Claim 1 to 4 provided with a part. 前記少なくとも1つの薬剤供給部は、上下方向に並んで配置された複数の薬剤供給部を含み、
前記被衝突部材の上下方向の長さは、前記複数の薬剤供給部の上下方向の並びの長さに対応しており、前記被衝突部材は一体的に形成されている、請求項1から5のいずれかに記載の薬剤供給装置。
The at least one drug supply unit includes a plurality of drug supply units arranged in a vertical direction,
The length in the up-down direction of the colliding member corresponds to the length of the plurality of medicine supply units arranged in the up-down direction, and the colliding member is integrally formed. The medicine supply device according to any one of the above.
前記緩衝部材は、発泡性樹脂で形成されている、請求項1から6のいずれかに記載の薬剤供給装置。   The said buffer member is a chemical | medical agent supply apparatus in any one of Claim 1 to 6 currently formed with the foamable resin. 前記被衝突部材は、超高分子量ポリエチレン樹脂で形成されている、請求項1から7のいずれかに記載の薬剤供給装置。   The drug supply device according to any one of claims 1 to 7, wherein the collision target member is formed of an ultrahigh molecular weight polyethylene resin.
JP2016179787A 2016-09-14 2016-09-14 Drug supply device Active JP6830642B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016179787A JP6830642B2 (en) 2016-09-14 2016-09-14 Drug supply device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016179787A JP6830642B2 (en) 2016-09-14 2016-09-14 Drug supply device

Publications (2)

Publication Number Publication Date
JP2018043767A true JP2018043767A (en) 2018-03-22
JP6830642B2 JP6830642B2 (en) 2021-02-17

Family

ID=61694347

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016179787A Active JP6830642B2 (en) 2016-09-14 2016-09-14 Drug supply device

Country Status (1)

Country Link
JP (1) JP6830642B2 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000085707A (en) * 1998-09-09 2000-03-28 Yuyama Seisakusho:Kk Ampoule bagging device
WO2005011563A1 (en) * 2003-07-31 2005-02-10 Yuyama Mfg. Co., Ltd. Medicine delivery device and medicine filling device
WO2010106944A1 (en) * 2009-03-16 2010-09-23 株式会社湯山製作所 Transfer means, drug dispensing system, and drug dispensing device
JP2010269819A (en) * 2009-05-21 2010-12-02 Asahi Glass Co Ltd Sheet material of glass plate packing body
WO2012070643A1 (en) * 2010-11-26 2012-05-31 株式会社湯山製作所 Tablet packaging device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000085707A (en) * 1998-09-09 2000-03-28 Yuyama Seisakusho:Kk Ampoule bagging device
WO2005011563A1 (en) * 2003-07-31 2005-02-10 Yuyama Mfg. Co., Ltd. Medicine delivery device and medicine filling device
WO2010106944A1 (en) * 2009-03-16 2010-09-23 株式会社湯山製作所 Transfer means, drug dispensing system, and drug dispensing device
JP2010269819A (en) * 2009-05-21 2010-12-02 Asahi Glass Co Ltd Sheet material of glass plate packing body
WO2012070643A1 (en) * 2010-11-26 2012-05-31 株式会社湯山製作所 Tablet packaging device

Also Published As

Publication number Publication date
JP6830642B2 (en) 2021-02-17

Similar Documents

Publication Publication Date Title
JP6262083B2 (en) Drug dispensing apparatus, hopper, and manufacturing method thereof
TWI430922B (en) Pharmaceutical packaging device
US8714405B2 (en) Device for staging and dispensing tablets useful in system and method for dispensing prescriptions
CA2683523C (en) Device for offloading capped vials useful in system and method for dispensing prescriptions
JP2011104077A5 (en)
US8061560B2 (en) Passive device for staging and dispensing objects
KR20110053925A (en) Medication containing container and medication distributing device
TW200422231A (en) Tablet packaging apparatus
JP2011125750A5 (en)
KR20120085677A (en) Automatic medicine packing machine
DE602005019736D1 (en) Dispense container for a blister pack of medicines
JP6387089B2 (en) Transport device for automatic drug packaging device
JP2005160607A (en) Medicine feeder
JP2018043767A (en) Medicine supplying apparatus
US782430A (en) Package-display cabinet.
CN109272650A (en) Goods discharging device
JP2018043766A (en) Medicine supplying apparatus
JP4967011B2 (en) Drug supply device
JP6932117B2 (en) Drug packaging machine
JP2011092349A (en) Medicine stock structure of dispenser
JP3202362U (en) Drug information display body, drug information display hook, drug information display mechanism of drug storage shelf
JP2007269371A (en) Medicine storage container
JP6845569B2 (en) Drug supply device
JP2023160919A5 (en)
US3743371A (en) Display and dispensing assembly

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20190227

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20190731

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190816

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200707

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200714

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200907

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210113

R150 Certificate of patent or registration of utility model

Ref document number: 6830642

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250